Resurgent Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Resurgent Financial Advisors's PFE Position: Q1 2026 in Review
Resurgent Financial Advisors increased its Pfizer (PFE) stake by 35% in Q1 2026, buying an estimated $353K and bringing the position to 50,987 shares worth $1.43M. The position accounts for 0.52% of the portfolio, ranked #46.
Resurgent Financial Advisors first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.5M in Q2 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Resurgent Financial Advisors held 50,987 shares of Pfizer worth $1.43M as of Q1 2026.
- Resurgent Financial Advisors bought 13,272 Pfizer shares in Q1 2026, an estimated $353K.
- Pfizer made up 0.52% of Resurgent Financial Advisors's portfolio in Q1 2026, its #46 holding.
- Resurgent Financial Advisors first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Resurgent Financial Advisors's Pfizer position peaked at $2.5M in Q2 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Resurgent Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.